Pharmaceutical Trade Remains Resilient in the Face of COVID-19
Director, Global Energy and Middle East, Stratfor
Apr 8, 2020 | 10:00 GMT
A photo of pill packets. The COVID-19 pandemic has raised serious concerns about the extremely high concentration of global pharmaceutical supply chains sourced from China and India.
(Shutterfly/Nenov Brothers Images)
The United States and many other countries are heavily dependent on supplies of pharmaceuticals and precursor chemicals from China and India. Widespread shortages resulting from the COVID-19 outbreak remain unlikely. Legislative proposals in the United States to force companies to "reshore" supply chains will likely falter on the increase in costs and regulatory hurdles. ...